Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 17/20 | 1.00 |
| ▸ | AURKB | Q96GD4 | 11/20 | 1.00 |
| ▸ | SRC | P12931 | 6/20 | 1.00 |
| ▸ | GSK3B | P49841 | 6/20 | 1.00 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 1.00 |
| ▸ | GSK3A | P49840 | 1/20 | 1.00 |
| ▸ | PDE5A | O76074 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29435815 | 1.00 | AURKA (1.00) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL24022423 | 0.94 | AURKA (0.88) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL802191 | 0.93 | AURKA (1.00) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL802209 | 0.90 | AURKA (0.82) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL802435 | 0.90 | AURKA (0.82) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL802159 | 0.90 | AURKA (0.80) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL31019653 | 0.90 | AURKA (0.80) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL801541 | 0.89 | AURKA (1.00) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL801605 | 0.88 | AURKA (0.79) | AURKAAURKBSRCGSK3BEIF2AK2 | |
| SCHEMBL29539480 | 0.88 | AURKA (0.77) | AURKAAURKBSRCGSK3BEIF2AK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12188046-B2 | Culture medium, coating matrix and method for expanding midbrain dopaminergic progenitor cells | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2025-01-07 | — | — | US | claimed |
| US-20240352419-A1 | METHODS AND COMPOSITIONS FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND DERIVED HEMATOPOIETIC LINEAGE CELLS | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2024-10-24 | — | — | US | claimed |
| US-20240327787-A1 | CULTURE MEDIUM, COATING MATRIX AND METHOD FOR EXPANDING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2024-10-03 | — | — | US | claimed |
| US-20240327788-A1 | CULTURE MEDIUM, COATING MATRIX AND METHOD FOR EXPANDING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2024-10-03 | — | — | US | claimed |
| US-20240316196-A1 | METHODS AND COMPOSITIONS FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND DERIVED NATURAL KILLER CELLS | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2024-09-26 | — | — | US | claimed |
| US-20240200027-A1 | CULTURE MEDIUM, COATING MATRIX AND METHOD FOR EXPANDING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS | NUWACELL BIOTECHNOLOGIES CO., LTD. (CN) | 2024-06-20 | — | — | US | claimed |
| CN-116121180-A | Media and methods for producing cardiomyocytes from pluripotent stem cells | 安徽中盛溯源生物科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-105143445-B | Maturation of hepatocyte-like cells derived from human pluripotent stem cells | 宝生物欧洲公司 | 2020-07-07 | — | — | CN | claimed |
| EP-2797596-B1 | PERITONEAL DIALYSIS FLUID COMPRISING A GSK-3 INHIBITOR | ZYTOPROTEC GMBH (AT) | 2019-06-26 | — | — | EP | claimed |
| US-10294457-B2 | Maturation of hepatocyte-like cells derived from human pluripotent stem cells | TAKARA BIO EUROPE AB (SE) | 2019-05-21 | — | — | US | claimed |
| WO-2014130411-A9 | TGF-BETA ENHANCING COMPOSITIONS FOR CARTILAGE REPAIR AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2014-10-16 | — | — | WO | claimed |
| WO-2014130411-A1 | TGF-BETA ENHANCING COMPOSITIONS FOR CARTILAGE REPAIR AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2014-08-28 | — | — | WO | claimed |
| WO-2014083132-A1 | MATURATION OF HEPATOCYTE-LIKE CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS | CELLECTIS SA (FR) | 2014-06-05 | — | — | WO | claimed |
| WO-2013098140-A1 | PERITONEAL DIALYSIS FLUID COMPRISING A GSK-3 INHIBITOR | ZYTOPROTEC GMBH (AT) | 2013-07-04 | — | — | WO | claimed |
| EP-2609918-A1 | Peritoneal dialysis fluid comprising a GSK-3 inhibitor | Zytoprotec GmbH (AT) | 2013-07-03 | — | — | EP | claimed |
| US-20130095567-A1 | DIRECTED DIFFERENTIATION AND MATURATION OF PLURIPOTENT CELLS INTO HEPATOCYTE LIKE CELLS BY MODULATION OF WNT-SIGNALLING PATHWAY | CELLARTIS AB (SE) | 2013-04-18 | — | — | US | claimed |
| WO-2010108005-A2 | NOVEL NEURAL PROGENITORS FROM PLURIPOTENT STEM CELLS, METHODS OF PRODUCING SAME AND USE TO PRODUCE NEURAL CELLS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 2010-09-23 | — | — | WO | claimed |
| US-20100166713-A1 | EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2010-07-01 | — | — | US | claimed |
| EP-2126045-A2 | EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2009-12-02 | — | — | EP | claimed |
| WO-2008094597-A2 | EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2008-08-07 | — | — | WO | claimed |